| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| fli1a | kdrl | ENSDARP00000071331 | ENSDARP00000134625 | Fli-1 proto-oncogene, ETS transcription factor a. | Vascular endothelial growth factor receptor kdr-like; Receptor for VEGF or VEGFC. Has a tyrosine-protein kinase activity. Combinations of multiple VEGF receptors are required for development of different blood vessel types in the embryo. Involved in angiogenesis, specifically in VEGF-induced sprouting of new blood vessels. Particularly involved in artery formation. Does not appear to be required for hematopoiesis. | 0.989 |
| fli1a | klf2a | ENSDARP00000071331 | ENSDARP00000062586 | Fli-1 proto-oncogene, ETS transcription factor a. | Kruppel-like factor 2a. | 0.614 |
| fli1a | notch1a | ENSDARP00000071331 | ENSDARP00000137942 | Fli-1 proto-oncogene, ETS transcription factor a. | Neurogenic locus notch homolog protein 1; Functions as a receptor for membrane-bound ligands Jagged-1 (JAG1), Jagged-2 (JAG2) and Delta-1 (DLL1) to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus. Affects the implementation of differentiation, proliferation and apoptotic programs. Involved in angiogenesis; negatively regulates endothelial cell proliferation and migration and angiogenic sprouting. Involved in the [...] | 0.723 |
| fli1a | notch1b | ENSDARP00000071331 | ENSDARP00000050854 | Fli-1 proto-oncogene, ETS transcription factor a. | Notch receptor 1b. | 0.588 |
| fli1a | tnnt2a | ENSDARP00000071331 | ENSDARP00000124963 | Fli-1 proto-oncogene, ETS transcription factor a. | Troponin T type 2a (cardiac). | 0.595 |
| heg1 | klf2a | ENSDARP00000012786 | ENSDARP00000062586 | Protein HEG; Receptor component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity. May act through the stabilization of endothelial cell junctions. | Kruppel-like factor 2a. | 0.671 |
| heg1 | klf2b | ENSDARP00000012786 | ENSDARP00000147221 | Protein HEG; Receptor component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity. May act through the stabilization of endothelial cell junctions. | Kruppel-like factor 2b. | 0.419 |
| heg1 | krit1 | ENSDARP00000012786 | ENSDARP00000138856 | Protein HEG; Receptor component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity. May act through the stabilization of endothelial cell junctions. | Krev interaction trapped protein 1; Component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity. Negative regulator of angiogenesis. Inhibits endothelial proliferation, apoptosis, migration, lumen formation and sprouting angiogenesis in primary endothelial cells. Plays a role in integrin signaling. Plays an important role in the maintenance of the intracellular reactive oxygen species (ROS) homeostasis to prevent oxidative cellular damage. Facilitates the down-regulation of cyclin-D1 (CCND1) levels required for cell transition from pr [...] | 0.999 |
| kdrl | fli1a | ENSDARP00000134625 | ENSDARP00000071331 | Vascular endothelial growth factor receptor kdr-like; Receptor for VEGF or VEGFC. Has a tyrosine-protein kinase activity. Combinations of multiple VEGF receptors are required for development of different blood vessel types in the embryo. Involved in angiogenesis, specifically in VEGF-induced sprouting of new blood vessels. Particularly involved in artery formation. Does not appear to be required for hematopoiesis. | Fli-1 proto-oncogene, ETS transcription factor a. | 0.989 |
| kdrl | klf2a | ENSDARP00000134625 | ENSDARP00000062586 | Vascular endothelial growth factor receptor kdr-like; Receptor for VEGF or VEGFC. Has a tyrosine-protein kinase activity. Combinations of multiple VEGF receptors are required for development of different blood vessel types in the embryo. Involved in angiogenesis, specifically in VEGF-induced sprouting of new blood vessels. Particularly involved in artery formation. Does not appear to be required for hematopoiesis. | Kruppel-like factor 2a. | 0.664 |
| kdrl | krit1 | ENSDARP00000134625 | ENSDARP00000138856 | Vascular endothelial growth factor receptor kdr-like; Receptor for VEGF or VEGFC. Has a tyrosine-protein kinase activity. Combinations of multiple VEGF receptors are required for development of different blood vessel types in the embryo. Involved in angiogenesis, specifically in VEGF-induced sprouting of new blood vessels. Particularly involved in artery formation. Does not appear to be required for hematopoiesis. | Krev interaction trapped protein 1; Component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity. Negative regulator of angiogenesis. Inhibits endothelial proliferation, apoptosis, migration, lumen formation and sprouting angiogenesis in primary endothelial cells. Plays a role in integrin signaling. Plays an important role in the maintenance of the intracellular reactive oxygen species (ROS) homeostasis to prevent oxidative cellular damage. Facilitates the down-regulation of cyclin-D1 (CCND1) levels required for cell transition from pr [...] | 0.570 |
| kdrl | notch1a | ENSDARP00000134625 | ENSDARP00000137942 | Vascular endothelial growth factor receptor kdr-like; Receptor for VEGF or VEGFC. Has a tyrosine-protein kinase activity. Combinations of multiple VEGF receptors are required for development of different blood vessel types in the embryo. Involved in angiogenesis, specifically in VEGF-induced sprouting of new blood vessels. Particularly involved in artery formation. Does not appear to be required for hematopoiesis. | Neurogenic locus notch homolog protein 1; Functions as a receptor for membrane-bound ligands Jagged-1 (JAG1), Jagged-2 (JAG2) and Delta-1 (DLL1) to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus. Affects the implementation of differentiation, proliferation and apoptotic programs. Involved in angiogenesis; negatively regulates endothelial cell proliferation and migration and angiogenic sprouting. Involved in the [...] | 0.901 |
| kdrl | notch1b | ENSDARP00000134625 | ENSDARP00000050854 | Vascular endothelial growth factor receptor kdr-like; Receptor for VEGF or VEGFC. Has a tyrosine-protein kinase activity. Combinations of multiple VEGF receptors are required for development of different blood vessel types in the embryo. Involved in angiogenesis, specifically in VEGF-induced sprouting of new blood vessels. Particularly involved in artery formation. Does not appear to be required for hematopoiesis. | Notch receptor 1b. | 0.786 |
| kdrl | tnnt2a | ENSDARP00000134625 | ENSDARP00000124963 | Vascular endothelial growth factor receptor kdr-like; Receptor for VEGF or VEGFC. Has a tyrosine-protein kinase activity. Combinations of multiple VEGF receptors are required for development of different blood vessel types in the embryo. Involved in angiogenesis, specifically in VEGF-induced sprouting of new blood vessels. Particularly involved in artery formation. Does not appear to be required for hematopoiesis. | Troponin T type 2a (cardiac). | 0.771 |
| klf2a | fli1a | ENSDARP00000062586 | ENSDARP00000071331 | Kruppel-like factor 2a. | Fli-1 proto-oncogene, ETS transcription factor a. | 0.614 |
| klf2a | heg1 | ENSDARP00000062586 | ENSDARP00000012786 | Kruppel-like factor 2a. | Protein HEG; Receptor component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity. May act through the stabilization of endothelial cell junctions. | 0.671 |
| klf2a | kdrl | ENSDARP00000062586 | ENSDARP00000134625 | Kruppel-like factor 2a. | Vascular endothelial growth factor receptor kdr-like; Receptor for VEGF or VEGFC. Has a tyrosine-protein kinase activity. Combinations of multiple VEGF receptors are required for development of different blood vessel types in the embryo. Involved in angiogenesis, specifically in VEGF-induced sprouting of new blood vessels. Particularly involved in artery formation. Does not appear to be required for hematopoiesis. | 0.664 |
| klf2a | klf2b | ENSDARP00000062586 | ENSDARP00000147221 | Kruppel-like factor 2a. | Kruppel-like factor 2b. | 0.849 |
| klf2a | krit1 | ENSDARP00000062586 | ENSDARP00000138856 | Kruppel-like factor 2a. | Krev interaction trapped protein 1; Component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity. Negative regulator of angiogenesis. Inhibits endothelial proliferation, apoptosis, migration, lumen formation and sprouting angiogenesis in primary endothelial cells. Plays a role in integrin signaling. Plays an important role in the maintenance of the intracellular reactive oxygen species (ROS) homeostasis to prevent oxidative cellular damage. Facilitates the down-regulation of cyclin-D1 (CCND1) levels required for cell transition from pr [...] | 0.684 |
| klf2a | notch1a | ENSDARP00000062586 | ENSDARP00000137942 | Kruppel-like factor 2a. | Neurogenic locus notch homolog protein 1; Functions as a receptor for membrane-bound ligands Jagged-1 (JAG1), Jagged-2 (JAG2) and Delta-1 (DLL1) to regulate cell-fate determination. Upon ligand activation through the released notch intracellular domain (NICD) it forms a transcriptional activator complex with RBPJ/RBPSUH and activates genes of the enhancer of split locus. Affects the implementation of differentiation, proliferation and apoptotic programs. Involved in angiogenesis; negatively regulates endothelial cell proliferation and migration and angiogenic sprouting. Involved in the [...] | 0.612 |